AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a ...
The latest investment brings the British pharma’s total investment at the site in Qingdao to $886 million. AstraZeneca ...
Researchers surveyed 385 women younger than 40 years with advanced breast cancer to gather insights about the challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback